Atrial fibrillation and stroke risk prevention in real-life clinical practice

This publication has 12 references indexed in Scilit:

• Risk factors and stroke risk stratification for atrial fibrillation: Limitations and new possibilities
  American Heart Journal, 2008
• Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'
  Thrombosis and Haemostasis, 2008
• Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis
  Thrombosis and Haemostasis, 2008
• Stroke and thromboembolism in atrial fibrillation: A systematic review of stroke risk factors, risk stratification schema and cost effectiveness data
  Thrombosis and Haemostasis, 2008
• Clinical and echocardiographic measures governing thromboembolism destination in atrial fibrillation
  Thrombosis and Haemostasis, 2008
• Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
  The Lancet, 2007
• Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation
  Annals of Internal Medicine, 2007
• Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation
  European Heart Journal, 2006
• Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry
  Published by Oxford University Press (OUP) ,2004
• Anticoagulation therapy for stroke prevention in atrial fibrillation. how well do randomized trials translate into clinical practice?
  ACC Current Journal Review, 2004